1. 323PSubcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis. (23rd October 2018) Authors: Kümmel, S; Tondini, C A; Abraham, J; Nowecki, Z I; Itrych, B; Hitre, E; Karaszewska, B; Juarez, A; Morales-Vásquez, F; Pérez García, J M; Cardona-Huerta, S; Heinzmann, D; He, J; Duc, A N; Crepelle-Fléchais, A; Martín, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 886 Auditory dysfunction in workers from a printing press exposed to organic solvents. (24th April 2018) Authors: Juarez, A; Aguilar, xxx; Trujillo, O; Fierro, D; Trejo, L; Madriga, C Journal: Occupational and environmental medicine Issue: Volume 75(2018)Supplement 2 Page Start: A411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗